Directory
Biotechnology company specializing in high quality, reliable research reagents for scientific research. Abbexa is a biotechnology company, specializing in high quality, reliable research reagents for scientific research. Bringing an integrated source of antibodies, proteins, ELISA kits and other biological reagents, the Company offers expert technical support, ensuring excellent quality through extensive validation. Abbexa collaborates with academic institutions, hospitals and laboratories across the world to provide a comprehensive product portfolio, which is available Worldwide through the Company’s ecommerce portal. As part of its continuous development, the Company works in the innovation of products to analyse new and challenging targets and provide solutions to key biological pathways.
Agenus uses the power of the immune system to develop innovative product candidates against cancer. Its technologies and candidates have the potential to treat cancer as well as other immune-mediated diseases. The company has assembled a broad portfolio of antibodies including checkpoint inhibitors and other checkpoint modulators, neo-antigen vaccines and adjuvants. Agenus’ strategy combines its intellectual and technical assets with its broad pipeline with the aim of bringing curative treatments to cancer patients.
Established in 1982, Alan Boswell Group is a top 15 independent insurance broker and one of the largest regional independent financial planners. We employ nearly 400 people from our eight offices across Norfolk, Suffolk, Cambridgeshire, and Lincolnshire. Our Cambridge team of more than seventy industry professionals all work together to provide a full range of commercial insurance, credit insurance, personal insurance, and financial services solutions to a wide customer base across the UK – many of them with worldwide operations.
As one of the industry’s leading cloud communications platforms for service providers, Alianza helps our customers supercharge growth and reduce costs while modernizing and transforming core communications networks. Our team of experts is passionate about simplifying service delivery and ensuring first-rate customer experiences. www.alianza.com
Altium is accelerating the pace of innovation through electronics. Our flagship product, Altium Designer®, is the software tool of choice for designers and engineers who create some of today’s most innovative electronics products. The growing demand for intelligent and connected products is driving advancements in electronics technology. Design trends demonstrate the need to minimize power, reduce package size and energy consumption, and prioritize high-speed design. For over 30 years, Altium has been delivering software that maximizes the productivity of PCB designers and electrical engineers, from concept to finished product.
AMD is the high performance and adaptive computing leader, powering the products and services that help solve the world’s most important challenges. Our technologies advance the future of the data center, embedded, gaming and PC markets. Founded in 1969 as a Silicon Valley start-up, the AMD journey began with dozens of employees who were passionate about creating leading-edge semiconductor products. AMD has grown into a global company setting the standard for modern computing, with many important industry firsts and major technological achievements along the way.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing and delivering innovative human therapeutics – focused on areas of high unmet medical need. Leveraging its biologics expertise, Amgen has been a biotechnology pioneer since 1980. Today it is one of the world’s leading independent biotechnology companies, reaching millions of patients globally. Amgen has more than 500 staff in the UK and Ireland, working across Commercial and Research & Development organisations. The UK & Ireland commercial Affiliate operates from offices in Cambridge, Uxbridge and Dublin. In R&D, Cambridge, along with Amgen’s office in Uxbridge, supports clinical development, regulatory affairs and other specialist R&D functions at local, European and global levels – including biostatistical sciences, safety, medical and quality/compliance. Cambridge Science Park was home to Amgen’s first UK office more than 25 years ago and has been at the forefront of Amgen’s European R&D organisation ever since. Today, Amgen’s UK R&D presence is one of the company’s largest hubs outside its global headquarters in Thousand Oaks, California. The UK & Ireland Affiliate is responsible for working with the health services across the UK and in the Republic of Ireland to support the company’s portfolio of medicines and progress its ultimate mission – to serve patients. www.amgen.comwww.amgen.co.uk
Analog Devices, Inc. (NASDAQ: ADI) is a global semiconductor leader that bridges the physical and digital worlds to enable breakthroughs at the Intelligent Edge. ADI combines analog, digital, and software technologies into solutions that help drive advancements in digitized factories, mobility, and digital healthcare, combat climate change, and reliably connect humans and the world. With revenue of more than $12 billion in FY23 and approximately 26,000 people globally working alongside 125,000 global customers, ADI ensures today’s innovators stay Ahead of What’s Possible. The team at Unit 204 is part of the Digital Healthcare Group focusing on Biomedical Development of new technologies.
Astex Pharmaceuticals is a leader in innovative drug discovery and development, committed to the fight against cancer and diseases of the central nervous system. Robust proprietary oncology portfolio with multiple drugs in mid-late stage clinical development Developing CNS portfolio of novel targeted therapeutics for defined neurodegenerative disease populations Productive partnerships with top-tier pharmaceutical companies Visionary leadership backed by a world-class management team Oncology and CNS Focused We are a leader in innovative small-molecule therapeutics with particular expertise in fragment-based drug discovery, the most important advance in discovery chemistry in the last 20 years. Our primary areas of focus are oncology and diseases of the CNS. Astex is developing a proprietary pipeline of novel targeted therapies and has a number of partnered products being developed under collaborations with leading pharmaceutical companies. In October 2013 Astex became a wholly owned subsidiary of Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan. The Otsuka Group employs approximately 43,000 people globally, and its products are available in more than 80 countries worldwide. For more information about Otsuka Pharmaceutical please visit our website.
As part of the Schneider Electric organisation, Spiral has a strong development focus with over two thirds of our staff in software development roles. We provide industry-leading technology for the process industries, focusing in particular on the oil and petrochemicals sector. We are committed to maintaining and building our technology lead making significant investments into research and development each year. Our tools are the established industry leader in crude oil selection and refinery modelling, allowing our clients to make optimal use of available feedstocks while maximizing safety and minimizing environmental impact. They play a business critical role for over 70 companies, including all the oil majors. Our supply chain toolset, launched in 2010, expands the scope of our tools into a much broader market encompassing planning, scheduling and logistics optimization. A strong development roadmap will continue to extend the end-to-end toolset capabilities as well as addressing other process industries, such as food & beverage, chemicals, mining and pharmaceuticals. Typically, global implementations of our tools span hundreds of users across an organisation. Full support for thin client and cloud-based implementations allows client companies to minimize implementation costs while maintaining high performance with granular control over access to data and services. Spiral’s tools run complex and computationally-demanding mathematical models to predict the behaviour of industry processes. The emphasis is on developing robust, highly optimized and scalable solutions. The Spiral toolset offers complete flexibility across desktop, web, mobile and programmatic interfaces, each of which interacts with a common business logic layer. work at spiral Spiral has a proven track record of attracting and retaining outstanding individuals. We pride ourselves on maintaining a positive, friendly work environment where extraordinary people can make the most of their talent, develop their skills and work as part of a great team. Our offices are located in the Cambridge Science Park, Europe’s longest-serving and largest centre for commercial research and development. The Science Park provides a number of facilities including a restaurant, bar, fitness centre, children’s nursery and an attractive landscaped environment for walking and jogging. Spiral’s modern offices provide facilities and technology of the highest standard, making for a comfortable and efficient work environment. Our spacious open-plan seating environment with daylight balanced lighting is complemented by meeting and breakout spaces for collaboration, private work and socializing with colleagues. We maintain a fully-stocked kitchen with daily deliveries of fresh, quality food for all staff. As you would expect from a leading-edge software company, our computing facilities are state-of-the-art including two large monitors for all staff and powerful development machines. We make the most of modern software to help make our work as productive and enjoyable as possible, including Pluralsight training and the latest versions of Microsoft development tools. Our development and QA engineers work as part of Agile teams with a focus on delivering innovative, high-quality software that exceeds our customers’ expectations. As part of the broader Schneider Electric Software organisation, we have access to a deep global pool of expertise and resources. We offer an attractive benefits package including an annual bonus scheme, a competitive contributory pension scheme, private health and dental cover, life insurance cover and a number of other benefits. opportunities Spiral is continuing to grow and we are looking for exceptional people to join our team across a wide range of roles. In software development, we are looking for talented programmers in a number of key skill areas including core business logic; scalable server components and cloud; web and desktop UI/UX; distributed high-performance computing; mathematical modelling and optimization. Our primary software development platform is Microsoft Windows with code written in C# and C++ using the latest language capabilities and libraries. We are also looking for QA engineers/software testers to work as part of our agile development teams, with particular interest in skills such as automated testing and QA for scalable web and SaaS solutions. In the area of delivery and support, we look for supply chain consultants, project managers and technical support consultants who work closely with customers to deliver successful solutions, along with IT specialists and Cloud Engineers to design and maintain our Cloud and SaaS solutions. Also lookout for opportunities in other areas including sales, marketing and technical authoring. More details can be found on the careers page on our website. If you would like to join our team, please apply via the Join Us page on our website.
AMD is the high performance and adaptive computing leader, powering the products and services that help solve the world’s most important challenges. Our technologies advance the future of the data centre, embedded, gaming and PC markets.
Founded in 1969 as a Silicon Valley start-up, the AMD journey began with dozens of employees who were passionate about creating leading-edge semiconductor products. AMD has grown into a global company setting the standard for modern computing, with many important industry firsts and major technological achievements along the way.
Bulgin, a Global Connectivity Consultancy that is widely recognised as a leading manufacturer of environmentally sealed connectors and components. With over 95 years of experience in the industry, our vision is to continue to innovate and develop products and services to cater for our global customer base across a variety of markets.
Bard Pharmaceuticals Ltd is the Production & Supply Chain business of the Napp Pharmaceutical Group. Bard is part of a broader network of independently associated companies that are present in 33 countries across Europe, and others throughout the rest of the world. At the forefront of controlled release technology, we manufacture, pack and supply products to over 40 countries, helping to bring benefits to many patients’ lives.
Science for a Better Life. As an innovative and research-based company, Bayer CropScience is committed to providing efficient and tailor-made solutions for its customers in the UK agricultural, garden and amenity markets. Committed to open communication, Bayer CropScience is setting the standard in areas of product and environmental stewardship.
Beko’s parent Company, Arcelik, has opened a global engineering and technology research centre on Cambridge Science Park. The centre will focus on areas that will contribute to the development of innovative products in the field of white goods with software design, new materials and advanced production technologies taking priority.
Biofidelity, a private company founded in 2019 in Cambridge, UK, is revolutionising access to best-in-class cancer diagnostics, breaking down the barriers to better screening, monitoring and treatment for all cancer patients. Our disruptive diagnostic technology platform provides comprehensive panels of clinically actionable data based on ultra-sensitive detection of the markers recommended in cancer treatment guidelines, enabling all patients to be prescribed the right drug at the right time. Biofidelity is developing panels for non-small cell lung and colorectal cancer, with potential in a broad range of cancers as well as in the detection of resistance to therapy and disease recurrence.
BOXERsolutions Ltd. is the provider of BOXER software to support simulation- especially Computational Fluid Dynamics. BOXERsolutions Ltd. provide advanced engineering simulation software leveraged off the research and development of its parent company, Cambridge Flow Solutions Ltd (CFS). We focus on providing practical, powerful and effective solutions that deliver unprecedented capability to real-world applications, irrespective of complexity and size.
BRDG (Bridge) is a next generation WorkTech social platform transforming how talent connects to opportunity by making trust, skill, and visibility the foundation of modern work. We support freelancers, students & creators (especially those from overlooked or underrepresented backgrounds) to get seen, get trusted, get hired and Connect. We solve three key problems and here’s how: Invisible talent – We replace static CVs with live visual profiles and proof-based productivity logs that show what you’re working on, not just what you’ve done. Fragmented trust – We eliminate fake reviews with biometric ID verification, smart contracts, and on-chain reputation tracking. Disconnected ecosystems – We unify hiring, learning, networking,and collaboration into one social, intelligent platform built for real world growth. BRDG is building the trust layer for the future of work, ensuring the opportunities of the future are accessible to everyone, no matter their circumstance. More information here: BRDG
Bright Horizons Cambridge Science Park cares for children from 3 months to 5 years of age, on a full time or part time basis. Open from 7.30am-6.00pm the nursery is fully inclusive providing hot healthy meals cooked on site, nappies, wipes, formula for babies and creams such as sun and nappy cream. Every age group has access to their own outdoor garden space and a large communal courtyard for all of the children to enjoy. Bright Horizons Cambridge Science Park is the chosen dedicated on-site nursery for Cambridge Science Park and we offer a perfect child care solution for all parents and employees located on the Science Park.Being located within a science park enables the nursery to suit the needs of working parents, offering a secure and versatile environment and simplifying drop-offs and pick-ups before and after work hours. With over 17 years total management experience, our nursery Manager Natasha May & Deputy Manager Rebecca Brown look forward to helping you choose your child care setting & showcasing our nursery to you. It is our mission to continue to make a difference to children, families and employers, and to provide the highest quality early care and education for each child in our nursery, every day. Bright Horizons Family Solutions is the UK’s leading childcare provider. With a portfolio of over 300 nurseries and a 30 year history, it has been trusted by many families to provide children with naturally inspiring, exceptional care and education for the early years.
Broadcom is a global leader in wired and wireless broadband communications semiconductors. Products enable the convergence of high-speed data, high-definition video, voice and audio at home, in the office and on the go. Broadcom provides manufacturers of computing and networking equipment, digital entertainment and broadband access products, and mobile devices with the industry’s broadest portfolio of state-of-the-art system-on-a-chip and software solutions.
At Bango we’re about making things thrive. We partner with leading brands across the world including Google, Amazon and Microsoft to shape the future of online commerce. It’s exciting stuff! The world’s largest online merchants, including Amazon, Google and Microsoft, use Bango technology to acquire more paying users. Bango has developed unique purchase behavior technology that enables millions more users to buy the products and services they want, using innovative methods of payment including carrier billing, digital wallets and subscription bundling. Bango harnesses this purchase activity into valuable marketing segments, called Bango Audiences. Merchants use these audiences to target their marketing at paying customers based on their purchase behavior. Better targeting increases spend through the Bango payments business, in turn generating more data insights, creating a powerful virtuous circle that drives continuous growth. Everyone connected to the Bango Platform thrives as the virtuous circle grows.
Mobile and web app developers specialising in apps for the health sector. Our team can help with app design, development, hosting and navigating the regulatory approval process, working with you to deliver tailored and innovative solutions.
Cambridge Flow Solutions (CFS) is a provider of proprietary software and services to support simulation – especially Computational Fluid Dynamics. Our team works in software development, research & collaboration with industry and in embedded consultancy roles. Our foundation brought together an extensive background in the three demanding and complementary areas of aerospace, turbomachinery and combustion, together with robust, validated in-house codes. We have since diversified into other application areas such as Motorsport, CAE, Oil and Gas, Energy and the Environment. Our experience in CFD has allowed us to identify the greatest gains to be made in improving simulation process software, together with the physical flow and industrial understanding required to build practical and useful applications.CFS’s main staff base is in our head office in Cambridge, and we also have a subsidiary company Boxer Solutions KK in Kobe, Japan. CFS is one of 3,500 technology firms in the ‘Cambridge Technopole’ region of innovative activity. With the city of Cambridge at its heart, it is one of the fastest growing economic regions of the UK.
The Next Wave Of Deep Tech Innovation Will Fundamentally Change The Way The World Works. Cambridge Future Tech Works To Make This Happen. The Cambridge Future Tech (CFT) Venture Builder is our vehicle for developing high potential businesses utilising innovative technologies in collaboration with innovators. The CFT team partner with founders from ‘Day-Zero’ working to turn nascent deep technology innovations into viable businesses with the resources and structure required for success. We drive the commercialisation of bleeding edge innovation. We work directly with researchers and inventors to commercialise their technologies. Our in-house team utilises expertise, contacts and resources to turn innovation into product and establish an effective route-to-market. We take on both fundraising and the building of a first class team. We start building customer relations early in the development process to ensure commercialisation is efficient and meets market needs. Cambridge Future Tech turns early technology and research projects into commercially viable ventures.
We are a medical device and algorithm company using artificial intelligence and computer science for the prevention of heart disease and stroke. We are also interested in the effect of inherited cardiac disorders as a common cause for electrical disturbances in the heart.
Cambridge Mechatronics Limited (CML) is a multidisciplinary engineering company developing industry-leading precision motion solutions for use across a variety of markets, including smartphones, AR/VR, wearables and many more.
Cambridge Science Centre makes science fun and friendly for all the family through our hands-on and interactive activities and exhibits. Open at weekends and during school holidays for family visits, you can buy your membership and enjoy a whole year of STEM-based exploration and discovery.
Building a better world for everyone The Cambridge Science Park was established 48 years ago when Trinity College Cambridge embraced the concept that would change the hi-tech sector in Cambridge, the UK and beyond. Trinity owns the freehold of the Cambridge Science Park, which today comprises 150 acres, 1.7 million sq ft of high technology and laboratory buildings. It’s home to 7500 people at over 100 companies, ranging from exciting start-ups to some of the world’s leading technology businesses. Companies and entrepreneurs at the Cambridge Science Park are working on life-enhancing technologies, ranging from non-invasive diagnostics and novel medicines to next-generation display and communications technologies, to name just a few. The wide range of occupiers in terms of size, sector, age and nationality offers unrivalled opportunities for collaboration, innovation and inspiration.
Employing the latest piezoelectric sensor design, 3D Multi-Touch provides an elegant solution to position and force sensing. The low cost force sensor needs no external power, adds no additional thickness or weight, and detects both location and force at the same time. 3D Multi-Touch allows one, two or more touches simultaneously, each with separate force detection, providing app developers with a whole new dimension to indulge their imagination. 3D Multi-Touch is next-generation technology that’s compatible with LCD and OLED displays, and unlike first-generation systems, fits above the display panel, significantly reducing manufacturing complexity and cost.
Cerevance is a new pharmaceutical company focused on central nervous system diseases. Our strengths include a powerful technology platform, a pipeline of novel discovery-stage and clinical-stage compounds and a proven team. We believe that we are well positioned to deliver life-changing therapeutics for patients who have brain-related disorders while creating value for our employees and shareholders.
Citrix aims to power a world where people, organizations and things are securely connected and accessible to make the extraordinary possible. Its technology makes the world’s apps and data secure and easy to access, empowering people to work anywhere and at any time. Citrix provides a complete and integrated portfolio of Workspace-as-a-Service, application delivery, virtualization, mobility, network delivery and file sharing solutions that enables IT to ensure critical systems are securely available to users via the cloud or on-premise and across any device or platform. With annual revenue in 2015 of $3.28 billion, Citrix solutions are in use by more than 400,000 organizations and over 100 million users globally.
CN Bio is a leading bioengineering company specialising in single and multi-organ microphysiological systems and innovative lab technologies. We aim to provide systems that generate clinically translatable data that can enhance the development of tomorrow’s medicines. Consumer goods, chemical companies and regulators use our microphysiological (MPS) systems and consumables to analyze novel compounds, assessing toxicity and safety in cells and organ models. We also support research scientists who need data-rich in vitro studies to investigate a wide range of biological processes in fields including oncology, infectious diseases, metabolism and inflammation. Our technologies enable researchers to work on innovative modalities including gene editing, therapeutic antibodies/proteins and cellular therapies.
Creasallis is a Cambridge based startup looking at re-engineering antibodies to improve their penetration into solid tumours. It has its own portfolio of solid tumour antibody-based drugs, as well as collaborates with antibody drug developers to improve their existing portfolio. www.creasallis.com
‘We are building a new method for instrument free single cell analysis’ Our transformative new technology for single cell genomics replaces complex hardware and manual time-consuming workflows with a simple, instrument-free, solution-based, kinetic confinement assay that plugs seamlessly into any molecular biology laboratory.
CW is the leading international community for companies involved in the research, development and application of wireless and mobile, internet, semiconductor and software technologies. With over 400 members from major network operators and device manufacturers to innovative start-ups and universities, CW stimulates debate and collaboration, harnesses and shares knowledge, and helps to build connections between academia and industry. CW’s 19 Special Interest Groups (SIGs) provide its members with a dynamic forum where they can network with their peers, track the latest technology trends and business developments and position their organisations in key market sectors. CW also organises major conferences and start-up competitions along with other high-quality industry networking events and dinners. With headquarters at the heart of Cambridge, UK, CW partners with other international industry clusters and organisations to extend its reach and remain at the forefront of global developments and business opportunities.
Cambridge Consultants is a world-class supplier of innovative product development and technology consulting. Working from our laboratories in Cambridge, UK, Boston and Seattle, USA, we have all the in-house skills needed to help you to create an innovative concept right the way through to taking your product into manufacturing. Most of our projects deliver prototype hardware or software and trials production batches. Equally, our technology consultants can help you to maximise your product portfolio and technology roadmap. We’re not content just to create me-too products that make incremental change; we specialise in helping companies achieve the seemingly impossible. We work with some of the world’s largest blue-chip companies as well as with some of the smallest, innovative start-ups who want to change the status quo fast. Founded over 50 years ago, the company combines exceptional people, proven processes and excellent facilities, backed by an enviable track record of creating world-firsts, to deliver real value to our clients. To find out more about our work please visit www.cambridgeconsultants.com We are one of the region’s leading employers and have been listed in ‘The Sunday Times Top 100 companies to work for’ list for the past three years.
With DisplayLink, expanding your visual workspace has never been easier or more affordable. Our technology makes it really easy to connect any display to any computer that supports USB or WiFi (which means any computer). We call this Plug and Display. DisplayLink is supported by the major PC computer and accessories companies and is designed into docking stations, graphics adapters, and monitors. We are constantly creating new ways to support other platforms and devices, including Ultra HD 4K displays, tablets, and wireless devices. We are a privately held company with offices in the USA, Asia and Europe.
Dr. Reddy’s Laboratories Ltd. is an integrated global pharmaceutical company with a commercial presence in more than 20 countries, and wholly-owned subsidiaries in US, UK, Russia, Germany and Brazil and joint ventures in China, South Africa and Australia. Dr. Reddy’s has over 20,000 employees working across the globe and a network of 25 manufacturing facilities and seven R&D centres, including Cambridge. In our Cambridge laboratories, Dr Reddy’s develops and uses advanced chemistry skills, including world-leading bio- and chemocatalysis technology, to develop routes to APIs. Projects are performed for both internal customers and, via our Custom Pharma Services division, for external customers. Our main focus is developing technical solutions for the production of complex single enantiomer intermediates and APIs. Our technologies enable cleaner, quicker, and more efficient routes to these target molecules. The site was founded more than 25 years ago and has been part of Dr Reddy’s since 2008.
Dassault Systèmes, the 3DEXPERIENCE Company, world leader in 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions, provides businesses and people with virtual universes to imagine sustainable innovations. Its 3DEXPERIENCE Platform leverages the Company’s world-leading 3D software applications to transform the way products are designed, produced, and supported, enabling businesses to craft delightful customer experiences.
Emberion develops and produces graphene photonics and electronics that will revolutionise infrared photodetectors and thermal sensors in applications ranging from hyperspectral and thermal imaging to night vision and X-ray detection. We deliver tailored, high-quality solutions for those in need of superior technical performance and improved return-on-investment in R&D. Our passion is to take imaging and sensing quality to a new level.
Everyone at Embrace has a shared ambition to do great work, to challenge thinking, create solutions and bold strategies that deliver beyond expectations. Our diverse experience and expertise allows us to implement global and local strategies across a broad range of contexts and geographies. We work with a strong group of partner suppliers who share the same ethos for producing excellence in communications and the event space.
Endomag is a global company headquartered in Cambridge’s Science Park, with an additional office in Austin, Texas. Originally founded in 2007 by professors at University College London (UCL) and the University of Houston, Endomag harnesses the power of magnetics to enable a better standard of cancer care. Many of the world’s leading physicians and hospitals use our technologies to help women with breast cancer avoid surgery when it isn’t needed, and experience better outcomes when it is. At the heart of the company’s product platform is the Sentimag® localisation system. The Sentimag® system features a probe that works like a metal detector, which when placed near the skin’s surface is used to detect Endomag’s magnetic seed (Magseed®) or liquid tracer (Magtrace®), for tissue localisation and sentinel node biopsy procedures. To date, the company has helped over 130,000 women around the world access more precise and less invasive breast cancer care.
EnSilica is a leading fabless supplier of complex mixed signal ASIC to OEMs and system houses. The company has world-class expertise in designing and supplying custom RF, mmWave, mixed signal and digital ICs to its international customers in the automotive, industrial, healthcare and communications markets. The company also offers a broad portfolio of core IP covering cryptography, Radar and communications systems. EnSilica has a track record in delivering high quality solutions to demanding industry standards. www.ensilica.com
Excelitas Noblelight Ltd is the market leader in the design and manufacture of high performance flash and arc lamps, utilised in several market areas including Laser (Industrial and Medical), IPL and Solar Simulation.
Finding faster and smarter ways to discover new and better drugs by actively applying AI to precision engineer medicines more rapidly and efficiently.
EDX Medical Group Plc. is a global specialist in digital clinical diagnostics; developing and supporting high-performance products and services to provide cost-effective prediction of disease risk, inform clinical decision-making, enable personalised healthcare and accelerate the development of new medicines for cancer, neurology, heart disease and infectious diseases.
FlexEnable’s award-winning flexible technology platform and unique FlexiOM™ materials bring the highest optical performance and lowest cost approach to flexible, ultra-thin and lightweight active optics and displays. The organic thin-film transistor (OTFT) backplane process developed by FlexEnable, allows transistors to be manufactured at less than 100°C – by far the lowest temperature process for transistor manufacturing in the world. This allows, for the first time, commonly available and optically ideal flexible bio-degradable substrates such as TAC film to be used instead of glass. FlexEnable’s game-changing technology is used to make active-matrix flexible displays and flexible active liquid crystal (LC) optical films which are thin, light and conformable to almost any surface. OTFT display technology is already on the market today incorporated into a consumer product – a crypto wallet device with an E Ink display uniquely wrapped around a 180-degree bend. Today, FlexEnable has around 450 patents and patent applications globally for OTFT and LC cell materials, processes and device architectures. With an established supply chain for OTFT production, FlexEnable has technology transfer programmes and mass production underway with several leading display manufacturers in Asia as well as commercial programmes with some of the world’s biggest brands in consumer electronics.
Frontier has built a uniquely diverse track record comprising games that have defined genres, been critically acclaimed and sold many millions of copies. Frontier is currently 250 strong and growing, as it recruits for its exciting next-generation games console projects.
World’s leading provider of Adaptive Behavioural Analytics technology. Featurespace is dedicated to making the world a safer place for our clients and their customers. Financial crime is an enormous issue for society – technology can combat it. With the support of our customers, we have developed market-leading solutions to fight financial crime – using real-time machine learning software powered by our invention – Adaptive Behavioral Analytics. Our technology and results are recognized as the best worldwide for fighting financial crime. With our scientific roots, we couldn’t make that claim if it had not been statistically verified – over and over again. Our achievements are due to our collaborative approach and ability to attract and retain the best customers, talent and investors. It’s a rare achievement to bring a new technology to market, to achieve financial success and – most importantly of all – to make customers proud to be using technology developed to outsmart the perpetrators of real-time financial crime.
We are a leading business adviser that helps dynamic organisations unlock their potential for growth.
Gearset is the complete, enterprise-ready Salesforce DevOps platform that empowers teams to deliver faster, safer, and more efficiently across the entire DevOps lifecycle. From metadata and CPQ deployments to CI/CD, testing, code scanning, sandbox seeding, backups, archiving, and observability, Gearset gives full visibility and control over your Salesforce environments. Trusted by over 3,000 organizations — including McKesson, IBM, and Zurich — Gearset combines advanced governance, built-in audit trails, and robust compliance with ISO 27001, SOC 2, GDPR, CCPA/CPRA, and HIPAA. Gearset enables teams to meet the highest standards of security and reliability. Designed for rapid onboarding and ease of use, Gearset delivers enterprise-grade power through an intuitive interface — uniting security, scalability, and simplicity in a single platform.
Heartfelt Technologies builds AI that improves the lives of heart failure patients. Heartfelt Technologies exists to help patients, their families, carers and doctors, to reduce hospital readmission rates from heart failure decompensation. We have developed a device with an optical sensor to automatically monitor heart failure in the home, whilst fitting naturally around the patient’s lifestyle. After a heart failure, patients are typically discharged and asked to monitor their symptoms daily, such as weight gain. Some will receive regular visits from healthcare professionals. It is well established that not all patients are able to keep up with the monitoring regimen recommended by their doctors and those who experience repeat admissions are often those who are unable to monitor their symptoms regularly. With the Heartfelt device, patients and their carers have one less thing to worry about with their often complex drug and monitoring routines; for the doctors this means consistently collecting data to help patients to live longer, healthier lives. As the device doesn’t require patients to remember to do anything to take measurements, we get 5 times more data with the Heartfelt device compared to the standard care (weighing scales) when used in patients’ homes. Most importantly, this regularity of data collection doesn’t reduce over time. The device can be easily installed in the patient’s home and will track the foot volume of the patient over time whenever the patient simply walks past the monitor. As leg œdema is one of the main symptoms associated with heart failure decompensation, it is one of the signs to keep an eye on. The data is then transmitted to ‘the cloud’ for further processing and flagging of high-risk patients. Once flagged, our data can feed into existing telemedicine monitoring systems allowing carers and medical professionals to take prompt action.
Hedera Innovations is a software development consultancy that enables organisations to bring complex embedded products to market quickly using Open Source Software. With over 15 years of expertise in the field we will guide you through the maze of design, component selection, tool chains, and licensing issues to enable you to maximise the benefits of using Open Source Software. We work closely with our clients to deliver technology components, customised development services and training and consultancy to meet your needs as and when required. Our approach emphasises working closely with the client throughout the entire lifecycle – from requirements capture to development, delivery and on-going maintenance. Our flexibility enables us to support both highly focused tasks and a complete turnkey solution.
Hereworks is an award-winning company that provides Smart Building solutions, including Master Systems Integration, along with our own patented software, Hereworks Happy™, a dashboard to provide insight into the information gathered from a Smart Building. Whether a complete digital transformation or an update to existing systems, Hereworks designs, installs, and implements digital infrastructures to meet their client’s unique requirements to connect and inspire their people. Hereworks draws on the experience of their people, as well as over 70 years of project management experience, to provide the best solutions.
UK and Global Insurance Broker specialising in Tech and Life Science Business, Construction, Haulage & Logistics, Hospitality and Manufacturing
We are a HR, Recruitment and Training Consultancy for SME businesses to the Technology, Insurance and Professional Services sectors. Providing personalised, professional people solutions that are based around the outcomes you’re hoping to achieve, rather than the challenges you’re faced with.
Huawei is a major investor in the UK, dedicated to help the UK to remain a leader in the global ICT sector. Huawei’s strategy is to build a better connected UK. Its technology and employees in the UK help to connect communities every day. Since it opened its first office in the UK in 2001, Huawei has grown from being a telecoms provider to a fully integrated ICT supplier. It is now a central player in the deployment of the UK’s broadband and telecoms networks and is partnering with all the major UK operators to deliver the fastest speeds and most comprehensive connectivity.
HUBER+SUHNER Polatis continues research into optical switching technologies. It has established a new performance benchmark for optical switches, based on patented DirectLight technology. This is being applied to create a non-blocking Direct Beam Steering (DBS) architecture, which points input and output fibres at each other, providing ultra low loss connections.
Our mission is to provide cutting edge satcom connectivity on-the-move – super fast, super reliable, interoperable. We are confident only we can deliver AESAs large and efficient enough for GEO, MEO, LEO and HEO – with no compromise on user experience. And we are closing in on our goal: the best enterprise-grade performance from all orbits. We have long-term, large-scale backing from Hanwha Systems, the South Korean leader in disruptive tech with big plans in air mobility and satcoms. It is building a LEO constellation for operation by 2025. Our AESA will be its terminal on Earth.
We manufacture super-adsorbent nanomaterials which can dramatically reduce the cost of separating, storing, and transporting gas. Separating, storing, and transporting gas using traditional technologies is costly and uses a great deal of energy. At Immaterial we work on an alternative technique that offers huge cost savings to industry through the use of metal-organic framework (MOF) materials that adsorb and separate gases at the molecular level.
We are the world’s first data-driven invention company. Our cutting-edge technology has powered the creation of over 1,500 patented inventions, showcasing the exceptional capabilities of our software and invention services. Iprova’s team of professional inventors create and deliver a stream of ready-to-use, and patent inventions within an agreed target area. Our partly contingent business model means we are strongly incentivised to create inventions that our clients – at their discretion – choose to accept. By exploring many millions of global changes in real-time, our software identifies and connects inventive signals, enabling the creation of new patentable inventions with unparalleled speed and efficiency. Find out more here
IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 87,000 employees, IQVIA conducts operations in more than 100 countries.
Ito solves transportation challenges across the globe for millions of travellers every day by delivering real-time data feeds for journey planning apps and a platform for transit authorities and operators. Ito works with some of the largest tech companies in the world powering multi-modal mobility solutions.
Ignota Lab specializes in advanced AI and machine learning solutions, driving forward the capabilities of data analysis and predictive modelling in various scientific fields.
Johnson Matthey’s vision is for a world that’s cleaner and healthier, today and future generations. We are leaders in sustainable technologies and we apply our science to solve our customer’s most complex problems. We work with customers and partners across markets from pharmaceutical and medical to automotive, industrial and chemical production.
A leader in creating deep and engaging experiences on PC and mobile, Jagex was founded in 2001 and is today one of the UK’s biggest and most respected video game developers and publishers Famed for its flagship MMOs RuneScape and Old School RuneScape, Jagex has welcomed more than 260million player accounts to its world and created a $1bn lifetime franchise revenue. Today the RuneScape franchise exists beyond running games in live operations; our titles are living games that connect and inspire millions of players, with content and experiences both inside and outside of inexhaustible game worlds. Both RuneScape and Old School RuneScape, on PC and mobile, offer ever-evolving, highly-active worlds and our community-focussed development ethos empowers players to have a real say in how each game is shaped. Jagex is expanding and extending its portfolio with fresh franchise titles, new IP and, in 2018 launched Jagex Partners, delivering third-party publishing and operational services exclusively for the living games of the future. Jagex employs more than 360 people at its Cambridge headquarters and is on the hunt for talented people to work across the business to help the company to achieve yet another year of record growth and player satisfaction.
We supply and install laboratory fume cupboards and furniture; our range is particularly designed for th laboratory and clean room markets as its manufactured from steel.
Lucideon’s Healthcare Materials Technologies office is based on the Science Park.
The Bradfield Centre is a purpose built collaborative scale up space in the heart of the world famous Cambridge Science Park. The building has been designed to encourage the collision of ideas and to spark creativity. By basing your tech business here you can enjoy inclusive access to everything we have to offer. The Bradfield Centre’s facilities are designed to accelerate businesses to new levels. The aim is to attract smart, ambitious, like-minded entrepreneurs and companies from both Cambridge and around the world; co-locate them in scalable, state-of-the-art facilities; immerse them in a collaborative, entrepreneurial culture; and connect them to investors, partners, mentors, advisers and potential customers. One goal in mind – to help grow Cambridge-based tech businesses to a large-scale.
Founded in 2001, Linguamatics is a world-leader in deploying innovative natural language processing (NLP)-based text mining for high-value knowledge discovery and decision support. We aim to produce software and solutions to help the pharma-biotech and healthcare industries speed up the drug-discovery cycle and improve patient outcomes.
MathWorks is the leading developer of mathematical computing software. Engineers and scientists worldwide rely on its products to accelerate the pace of discovery, innovation, and development. MATLAB, the language of technical computing, is a programming environment for algorithm development, data analysis, visualization, and numeric computation. Simulink is a graphical environment for simulation and Model-Based Design for multidomain dynamic and embedded systems. MATLAB and Simulink are also fundamental teaching and research tools in the world’s universities and learning institutions. Founded in 1984, MathWorks employs more than 5000 people in 16 countries, with headquarters in Natick, Massachusetts, USA.
MicrosensDx is a dynamic and ambitious innovator at the leading edge of the diagnostics sector for more than 20 years. MicrosensDX is building a global brand, delivering sample to result molecular solutions, transforming patient outcomes with fast accurate diagnosis. Our vision is to build a global brand delivering innovative diagnostic solutions which transform patient outcomes. Our dedicated team is aligned to our mission of building a global brand, delivering sample to result molecular solutions, transforming patient outcomes with fast accurate diagnosis.
At Microsoft in Cambridge, our mission is to transform the world through deep research. We do this by working together in an interdisciplinary way, in close collaboration with the broader Microsoft business, to ensure that we are designing robust and trusted technologies to empower millions of people worldwide. To truly understand how we can empower others, we need to put the people at the centre of what we do. In a hybrid world the dynamics of how we work, communicate and feel a sense of connection with others is evolving, which is a significant opportunity for our research. The site incorporates custom-made, state-of-the-art, optical labs and office space, for the Cloud Systems Futures team and Azure for Operators team.
Milltons brings together patients and researchers in order to find new therapeutic approaches to painful yet neglected chronic illnesses. We are building an ever-growing community of patients, researchers, medical associations and universities actively involved in large-scale Pan-European studies. Together, we are devising new therapeutic mechanisms to ease the pain and stop deterioration of the illnesses. During the current COVID 19 situation, we have built a charitable program designed to reduce stress, inflammation and degeneration for chronic patients; conditions which are all accelerated by quarantine. Our members will be able to learn, implement and, most importantly, measure their progress in all 3 stages- reducing stress, reducing inflammation and slowing down cellular degeneration.
Mogrify® has developed a proprietary suite of platform technologies that utilize a systematic big-data approach to direct cellular reprogramming (Rackham et al., Nature Genetics, 2016) and the maintenance of cell identity (Kamaraj et al., Cell Systems, 2020). The platforms, MOGRIFY® and epiMOGRIFY®, developed over a 12-year period via a multi-national research collaboration, deploy next-generation sequencing, gene regulatory and epigenetic network data to enable the prediction of the transcription factors and growth factors required to produce any target human cell type from any source human cell type. The platforms can be used to enhance existing stem-cell forward programming methods, or can bypass development pathways altogether, affecting a direct transdifferentiation between a mature cell type to another mature cell type. Mogrify is applying its proprietary and award-winning platforms to generate the functional cell types required to transform the lives of patients, by delivering a novel class of in vivo reprogramming therapies across ophthalmology, otology, metabolic and other areas of degenerative disease. Uniquely positioned to address a regenerative medicine market estimated to be worth $150 billion USD by 2028, Mogrify is commercializing its technology via a combination of in vivo reprogramming therapy development, co-development partnerships, as well as the exploitation of the platform in other therapeutic and non-therapeutic applications. Based in Cambridge, UK, the Company has raised over $40 million USD funding from Parkwalk, Ahren Innovation Capital, 24Haymarket, Trend Investment Group, Dr. Darrin M. Disley, OBE, Dr. Jonathan Milner and the University of Bristol Enterprise Fund III, as well as strategic investors; Astellas Venture Management.
Mulberry Risk are a boutique consultancy providing actuarial, analytical and capacity management services to MGAs. Our vision is to help them outperform incumbent insurers’ returns. In pursuit of this vision, our mission is to partner with MGAs and deliver actuarial, analytical, and capacity management services, efficiently, and at an affordable price. We built ourselves to be very different from the legacy of the actuarial consulting world. The old model uses a heavy headcount, can be slow to meet challenging client needs and relies too heavily upon a structure that in today’s world is outdated. We embrace technology and use it to create a scalable platform and solution that delivers high-end analysis, efficiently and effectively. Every day, we help MGAs be better than insurers, supporting their agility with our innovation.
Mundipharma International Limited is part of a global network of independent associated privately owned pharmaceutical companies which was founded by physicians more than 60 years ago to help improve the health and quality of life of people everywhere. Working across 23 countries in Europe, we partner with organisations to accelerate the development of medicines and have a proven track record in building brands that maintain leading positions. We look at things from a different perspective and are expert at identifying and developing the potential of medical innovations to help improve patients’ lives in meaningful ways. We develop medical innovations by collaborating with research institutions and partner companies that can, with our expertise and support, achieve their full potential and create shared value for stakeholders. We are successfully developing an increasingly diversified portfolio of medicines built on our proud heritage of over 60 years in pain management We recognise the pressures on healthcare systems and believe that the only innovations that matter are the medicines that are successfully launched and made available for the benefit of patients. We therefore take a pragmatic approach to assessing pharmaceutical innovation in order to develop responsible and sustainable medicines that create shared value.
Mundipharma IT Services helps its clients to improve patients’ lives. The company understands how to use IT to transform businesses and creates value by building and operating cost effective solutions all around the globe.
The 21st century will be marked by the convergence of artificial intelligence, fuelled by Moore’s Law (‘Mursla’ pronounced in Japanese), and the increasing ability to decode the complex language of biology (‘Bio’) Mursla Bio
Pioneers in virtual reality applications for neuroscience, Neuro XR creates immersive environments that aid in the study and treatment of neurological conditions.
NextMove Software develops innovative informatics solutions to support strategic decision making in the pharmaceutical and chemical industries.
Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise, and more advanced sequencing capacity in the world. Novogene utilizes scientific excellence, a commitment to customer service and unsurpassed data quality to help our clients realize their research goals. The company has become a world-leader in NGS services, with 2,600 employees and multiple locations across the globe. Novogene’s depth of experience has resulted in the ownership of 22 NGS-related patents, as well as the publishing of over 4920 customer research papers, often in well-respected publications such as Nature and Science . Company founder, Dr. Ruiqiang Li , is widely recognized as one of the world’s leading experts in genomics and bioinformatics, owning 17 patents and has authored over 100 publications that have been cited more than 42,000 times. Best known for developing the software SOAP ( Short Oligonucleotide Analysis Package) for ultra-fast sequence mapping, variation detection, and de novo genome assembly, Dr. Li has focused Novogene’s services on performing sequencing AND Advisory informatics to fully empower and enable our customers to move forward rapidly and effectively in their scientific Endeavors.
Nyobolt is commercializing high-power, ultra-fast-charging Li-ion batteries. The company’s technology builds on a decade of battery research led by University of Cambridge battery scientist Professor Clare Grey and is exclusively licensed from the University. Nyobolt has assembled a world-leading implementation team combining decades of experience at Tesla, Lotus, Samsung, Dupont, Dyson, General Electric, A123, Innovate UK and Arthur D. Little through operations in the UK, US, and Asia. The company recently secured $10 million in Series A funding to build pilot facilities and grow engineering and application capabilities.
Napp is a privately owned UK company with a strong track record in bringing high quality, innovative medicines to UK health professionals and their patients. Napp provides prescription only medicines for respiratory diseases, such as asthma, inflammatory conditions, such as Crohn’s disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritisand psoriasis, as well as pain management, blood cancers and cardiovascular conditions. Based in the heart of the Cambridge science community, and part of a worldwide network of independent associated companies across 48 countries, Napp prides itself on being an ambitious, asset led, customer-focused and sales driven organisation.
Developing a breathalyzer for disease – with a focus on non-invasive diagnostics for cancer, inflammatory disease and infectious disease, the company aims to save 100,000 lives and $1.5B in healthcare costs. Owlstone Medical’s mission is to save 100,000 lives and $1.5 billion in healthcare costs by developing Breath Biopsy® for applications in early detection and precision medicine across a wide range of diseases. Breath Biopsy detects biomarkers on breath such as volatile organic compounds (VOCs) and respiratory droplets. VOC biomarkers originate from within the body as a result of metabolic and disease processes as from external sources including diet, environmental exposures and the microbiome. They are carried in the blood and exchange into breath in the lungs. Respiratory droplets arise in the lungs and are a medium for respiratory disease transmission as well as a source of macromolecular and non-volatile biomarkers. Owlstone Medical is establishing a new diagnostic modality in breath with distinct advantages over existing approaches. The company offers an end-to-end platform for sample collection and analysis to support clinicians, academics and pharmaceutical researchers. Their Breath Biopsy Collection station, including ReCIVA® Breath Sampler enables non-invasive sampling with background reduction and pre-concentration to maximize sensitivity. Owlstone Medical provides comprehensive sample analysis services through the Breath Biopsy OMNI Assay that delivers high quality biomarker discovery, identification and validation using Thermo Fisher™ GC-Orbitrap™ technologies. You can also target specific processes for precision analysis with EVOC® Probes; using administered exogenous VOCs to precisely assay metabolic pathways of interest.
Oxford Gene Technology (OGT) provides world-class genetics research solutions to leading clinical and academic research institutions. Founded by Professor Sir Edwin Southern, and with customers in over 60 countries worldwide, OGT has a strong reputation and increasing share in the large and growing genomic medicine market. The Company’s Cytocell®, CytoSure™ and SureSeq™ range of fluorescence in situ hybridisation (FISH), microarray and next generation sequencing (NGS) products deliver high-quality genetic analysis, enabling accurate identification and confirmation of the causative variation underlying genetic disease. OGT was acquired by Sysmex Corporation (Sysmex), a Japanese in vitro diagnostic company in June 2017. The acquisition of OGT expands Sysmex’s life science business and reinforces its initiatives towards personalised medicine.
Origami is a technology company with the vision to build a real-time marketplace for the distributed energy world. The ever-increasing global demand for electricity requires a proactive approach to the use of existing energy assets and their flexibility to avoid significant investment in generation and distribution networks. Energy flexibility (ability of an energy asset to turn up/down or on/off) is becoming increasingly valuable to help balance electricity systems around the world, as increasing amounts of inflexible and intermittent renewable generation is added to the energy mix. We have developed intelligent, versatile and secure technology to optimally generate value from this flexibility, in real-time. This technology enables new renewable generation to be added to electricity systems at the most efficient capital cost; flexibility providers to generate better financial returns from their assets; and flexibility users to buy, sell and trade better. We provide our technology through strategic partnership agreements with energy suppliers and traders. We also provide fully funded, turnkey energy storage solutions designed to reduce bill costs, generate new income streams and enhance energy security. Our technology is architected to deliver global solutions and is already tested and commercially proven in the highly deregulated UK energy market.
New and revolutionary mechanical testing methods and products Plastometrex is a technology company formed by a team of materials scientists, all formerly of the University of Cambridge. The company combines advanced numerical methods with novel hardware systems to create new and revolutionary mechanical testing methods and products. Plastometrex’s flagship product, the benchtop Indentation Plastometer, is a mechanical test device that extracts accurate metal stress/strain curves from a 3-minute indentation test. Since launching in 2020, the technology is already being used by leading companies and universities across the world, including Element Materials Technology and The University of Oxford.
Pragmatic Semiconductor is a world leader in ultra low cost flexible electronics, enabling the potential for trillions of “smart objects” that can sense and communicate with their environment. Pragmatic Semiconductor’s unique technology platform enables integrated circuits thinner than a human hair that can be easily embedded in any surface, introducing interactivity into a wide range of everyday items. At a fraction of the price of conventional silicon chips, Pragmatic Semiconductor’s products enable a vast range of new applications: from intelligent packaging of fast-moving consumer goods, to wireless traceability of documents for security and identification. Pragmatic Semiconductor is headquartered in Cambridge, England and has a production facility based at the National Centre for Printable Electronics in Sedgefield. Pragmatic Semiconductors growing customer base includes large multi-national customers across a number of sectors, including consumer goods, packaging, security printing and mainstream electronics.
Sustainable bio-based material for fashion PACT’s mission is to reduce the environmental impact from raw materials used in fashion, which is the main path in making this industry less polluting and more sustainable. Leather has one of the highest impacts, including water pollution with heavy metals, significant land use and carbon footprint as it derives from the cattle industry. By turning waste-derived collagen into a biomaterial that mimics leather, we create a scalable environmentally-friendly, sustainable and bio-based substitute to leather.
Roku pioneered streaming for the TV, & we aspire to power every TV in the world. We developed a streaming platform that delivers a best-in-class user experience. At the heart of the Roku platform is our proprietary operating system, the Roku OS, which we built from the ground up. Roku is recognized for streaming innovation
Roundpoint has developed and managed mobile services and apps right from the start of ‘mobile’ itself. Today our focus is on scholarly publishing and learning services for professional societies and medical associations. Our expertise involves the creation of an online platform designed to simplify the process of building and managing digital learning to the highest standards.
With over 54,000 members and an international publishing and knowledge business we are the UK’s professional body for chemical scientists, supporting and representing our members and bringing together chemical scientists from all over the world. A not-for-profit organisation with a heritage that spans 175 years, we have an ambitious international vision for the future. Around the world, we invest in educating future generations of scientists. We raise and maintain standards. We partner with industry and academia, promoting collaboration and innovation. We advise governments on policy. And we promote the talent, information and ideas that lead to great advances in science. In a complex and changing world, chemistry and the chemical sciences are essential. They are vital in our everyday lives and will be vital in helping the world respond to some of its biggest challenges. We are committed to promoting, supporting and celebrating inclusion and diversity. We understand that the success of our community depends on our ability to nurture the talent of the best people regardless of who they are or their background. We’re working to shape the future of the chemical sciences – for the benefit of science and humanity.
Computing for everybody. From industries large and small, to the kitchen table tinkerer, to the classroom coder, we make computing accessible and affordable for everybody.
Simba HPC is an electronics design house specialising in hardware, software, and FPGA development for digital signal processing and accelerated computing.
SCT is a leader in the design, manufacture and supply of Industrial IoT devices, sensors and AI-driven cloud applications for remote condition monitoring in rail, energy and mining.We transform critical infrastructure operations through actionable insights with smart monitoring solutions designed for predictive and preventative maintenance.Our solutions extend asset life, reduce maintenance costs and delays, and avert catastrophic failures. SCT has a multidisciplinary team for in-house electronics, mechanical and software design, development, testing and production. This means the company can develop new products rapidly in response to changing market needs, with its R&D hub acting as an incubator for fresh ideas. SCT’s focus on predictive and preventative maintenance means there is an appetite to respond to new requirements and facilitate potential future development based on a consultative approach with customers.
Technology and Professional Recruitment Services SoCode offer a highly personalised and consultative recruitment solution operating in the Technology and Professional Services Sector. Founded by genuine recruitment industry leaders, our multi-award-winning team spans over a decade of recruitment expertise. Specialising within the Cambridge market, and reaching across the east of England we have built strong relationships across our specialised sectors. We operate out of Norwich and now Cambridge with our recent expansion to the Cambridge Science Park following on from our highly successful growth. Since our launch in 2016 we have made over 600 placements in Cambridge, -making us one of the most successful independent recruitment start-ups’ in the UK. We achieved this with our successful formula of offering a highly personalised and consultative recruitment solution to Start Up, High Growth and Blue-Chip Clients. Unlike most recruitment companies we are not driven by KPI’s or Sales but by our customer satisfaction and service delivery levels. Linked in
Speechmatics® powers applications that require mission-critical, accurate speech recognition using its any-context #speechrecognition engine. Our story began back in the 1980s, when our Founder Dr Tony Robinson, pioneered the approach of applying neural networks to speech recognition, demonstrating that neural networks greatly outperform traditional systems. Today’s computing power, along with the rise of graphics processing and cloud computing, now makes the huge potential of this approach a reality and we’re nearing the point where computers truly understand us. At Speechmatics, we’re continually pushing the boundaries of automatic speech recognition (ASR) accuracy in many languages. Because of our advancement in accuracy and languages, our speech recognition technology continues to be adopted by some of the largest blue-chip companies in the world. Already, the practical applications for our technology is changing the way companies work. Hugely tedious and laborious tasks can be automated, and the value of both live and recorded media can be extracted. We’re excited by what it helps you to do, and we’re only just getting started.
SwiftDx’s portfolio of patented technologies enable ultra-boosted sensitivity lateral flow diagnostics for diseases which are undetectable with current lateral flow test technology.SwiftDx has successfully completed the initial technology development phase and is ready to commercialise its DNA detection and eAMP technologies. The company’s first product (the SwiftDx Mycoplasma Detection kit) has been launched and a further products are in development. SwiftDx’s goal is to better inform patients and healthcare practitioners with a new generation of lateral flow tests.
We harness the natural properties of sustainably sourced seaweed, to create the best replacements for plastics. After use, our biodegradable products return to the soil to nourish it.
Discovering innovative cancer therapies. From initial concept to the delivery of candidate drugs – we’re a drug discovery company specialising in cutting-edge cancer treatment.
SI Sensors is a division of Specialised Imaging Limited based in Cambridge and focused on Advanced Image Sensor Development. Specialised Imaging Limited is a dynamic company focusing on the design, manufacture, service and supply of ultra-high-speed imaging systems and components for industrial, defense and scientific applications.
Sigma-Aldrich, now part of Merck, is a global leader in the Life Science Industry. We offer a broad portfolio of more than 300,000 products, including many of the most highly respected brands in the industry. Our offerings span every step of the biotech/biopharma production chain, creating a complete end-to-end workflow with enhanced customer service, a simplified interface and a leading e-commerce and distribution platform.
Sandoz (SIX: SDZ; OTCQX: SDZNY) is the global leader in generic and biosimilar medicines, with a growth strategy driven by its Purpose: pioneering access for patients. More than 20,000 people of 100 nationalities work together to ensure 900 million patient treatments are provided by Sandoz, generating substantial global healthcare savings and an even larger social impact. Its leading portfolio of approximately 1,300 products addresses diseases from the common cold to cancer. Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. Its history of breakthroughs includes Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the world’s first biosimilar in 2006. In 2024, Sandoz recorded net sales of USD 10.4 billion. www.sandoz.com
Tesu Health, established in January 2022, is a forward-thinking prescription digital therapeutics (DTx) start-up dedicated to providing effective treatment solutions for individuals facing chronic diseases. Our strides since inception are attributed to a proficient team of experts in software engineering, clinical medicine, pharmaceuticals, and private health insurance. Now headquartered in the esteemed Cambridge Science Park, Tesu Health is poised for global expansion. Our focus on research and development, coupled with robust sales and marketing initiatives, aims to propel us into the international arena, with the ultimate vision of becoming a leading global digital therapeutics company. Anchored by a well-defined business plan encompassing market analysis, financial projections, and a strong management team, Tesu Health is confident in its ability to deliver positive outcomes for investors, customers, and stakeholders. In essence, our innovative fusion of cutting-edge technology and clinical expertise positions Tesu Health as a transformative force in reshaping the treatment paradigm for individuals with chronic diseases.
Defining a new category of food ingredient: sugars from fiber The Supplant Company is defining a new category of food ingredient: sugars from fiber. With Supplant™ sugars from fiber, your favorite treats can look, feel and taste like they’re supposed to. But because it’s made from fiber, Supplant™ sugars from fiber is lower in calories, has a low glycemic response compared to glucose, and is prebiotic. It’s made by upcycling agricultural side streams: fiber-rich parts of crops that are hugely abundant and don’t typically make their way into the food system. The Supplant Company was founded by Dr. Tom Simmons and has raised over $26 million in venture capital financing and is backed by major VCs in the US and Europe. We enjoy solving complex problems, advancing our knowledge and driving our mission forward. We are focussed on creating a great work environment where smart and engaged people tackle meaningful challenges and make an impact. We know that nothing happens if you don’t love what you’re doing: we’re committed to doing the right thing and having fun along the way.
The Cambridge Research Laboratory (CRL) was Toshiba’s first overseas corporate R&D laboratory. Established in 1991, CRL is a world leading industrial research centre dedicated to fostering innovation through basic and applied research in physics, engineering and computer science. Its research areas include quantum information processing, speech and computer vision technology.
We’re part of China’s largest family of nearly 200 innovation spaces, present in every major city in China, and our mission is to help startups, businesses and organizations in the UK to enter the Chinese market easily and securely. We invite you to join us and to work with us: either through one of our science parks in Cambridge and Newcastle, or as a national partner interested in cross-border activity with China.
Helping people from all backgrounds to learn the practical and personal skills needed to be a great employee Tech Educators provide instructor-led Software Development Bootcamps and Unity Game Development Bootcamps and help people from all backgrounds to learn the practical and personal skills needed to be a great employee.
Vectura is an emerging pharmaceutical company developing a range of inhaled drugs for the treatment of lung diseases and conditions where delivery via the lungs can provide significant benefits. Vectura also actively licenses out its inhalation device and formulation technologies for product applications of other pharmaceutical companies and can provide pharmaceutical development support to its licensing partners and other long-term collaborators.
Full service European intellectual property firm
Veranova is a global leader in the development and manufacturing of specialist and complex active pharmaceutical ingredients (APIs) for pharma and biotech customers. Cambridge Veranova is an established provider of solid form services, including polymorph studies, salt selection, co-crystallization, chiral separations and process scale up that are critical to successful drug discovery and development.
Vital Signs Solutions is an early-stage, venture backed company with a founding team that has over 30 years experience in point of care diagnostics, consumer technology and healthcare. We have an extensive network of some of the best investors and advisors across the medtech, digital health and consumer technology sectors. Why are we doing what we’re doingSome of the biggest cost-centres and most fatal diseases in the world today can be prevented through individuals making personal changes to the way they lead their lives. Traditional health & care solutions are struggling under the weight of increased demand for services with restricted financial resources and are based on a paradigm which treats the disease – not preventing the disease occurring in the first place. Many of the major global health problems can only be overcome through solutions that allow people to manage their own health, so called “self management” or “patient activation”. We are developing these solutions in conjunction with health & care professionals, to ensure they align with the major public health priorities and standards.
Vitrolife is a global company contributing products within the IVF field. Our mission is to support customers to achieve successful treatment outcomes by providing valued solutions and services for assisted reproduction. Founded in 1994 Vitrolife was one of the first companies providing IVF laboratories with high quality ready-to-use culture media. Today our portfolio holds products all the way from oocyte retrieval to transfer of the embryo and cryopreservation. Vitrolife has approximately 400 employees and the headquarter is located in Sweden with additional locations and production facilities in more than ten countries world-wide. The Vitrolife share is listed on NASDAQ OMX Stockholm, Nordic Large Cap. Together with our customers, our mutual skills and experiences, we successfully treat infertility. Together. All the way.
VaxEquity is a UK biotechnology company developing next generation self-amplifying RNA and mRNA therapeutics and vaccines. Our proprietary RNA platform is designed to modulate the innate immune response to enable higher and longer protein expression allowing lower doses and expanding the potential of RNA for therapeutics as well as vaccines. VaxEquity was founded in 2020 by Imperial College London’s Professor Robin Shattock, and specialist life sciences investor Morningside, and is led by a world class team who are RNA pioneers. The Company is based in Cambridge, UK, and is collaborating with AstraZeneca to progress its platform across multiple disease areas.
Worldpay is a leading payments company with global reach. We provide an extensive range of technology-led payment products and services to over 400,000 customers, enabling their businesses to grow and prosper. We manage the increasing complexity of the payments landscape for our customers, allowing them to accept the widest range of payment types around the world. Using our network and technology, we are able to process payments from geographies covering 99% of global GDP, across 146 countries and 126 currencies. We help our customers to accept more than 300 different payment types.
Integrated photonics uses the same scalable process used to make semiconductor electronics chips to make circuits for light. It’s being used as the platform for energy-efficient communications for AI and data centres, wearable healthcare sensors, rapid diagnostic tools, optical tensor processors, on-chip lidar, quantum technologies and a host of other transformative applications. Wave Photonics is building design technology to enable and accelerate the development, mass production and adoption of these technologies. Wave Photonics
XGenomes’ mission is to revolutionize precision research and medicine through streamlined sample-to-answer solutions that exceed existing technologies across several metrics. XGenomes’ platform leverages super-resolution single-molecule imaging, deep learning and novel sequencing chemistry.
Natural alternatives to single-use plastic Xampla has created the world’s first plant protein material for commercial use. Our next generation material performs like synthetic polymers, but decomposes naturally and fully, without harming the environment. Our mission is to replace the everyday single-use plastics you see all around, like bags, sachets and flexible packaging films. And the less obvious, such as microplastics within liquids and lotions.
Yagro Ltd provide data insights to the agricultural industry. We help you make smarter, more informed decisions to mitigate risk, grow your business, improve efficiency or simply increase your knowledge base. Our software is designed to make use of your pre-existing farm data to find and highlight valuable insight to meet your individual business needs. It’s like having an analyst on your team who can work around the clock crunching numbers for you, but without the cost of hiring a full-time employee.
